Antelope Valley Clinical Trials

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Asthma3 trials
• Atopic dermatitis (eczema)3 trials
• COPD1 trial

Phase

• Phase 23 trials
• Phase 33 trials
• Phase 41 trial

Status

• Active, not recruiting4 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Acrotech Biopharma Inc.1 trial
• Bluefin Biomedicine, Inc.1 trial
• Bond Avillion 2 Development LP1 trial
• Eli Lilly and Company1 trial
• Pfizer1 trial
• and 2 more

Running trials

• Active, not recruiting

  A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

  NCT07105488· Phase 2· Bluefin Biomedicine, Inc.· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  NCT06977581· Phase 2· Pfizer· Source

• Active, not recruiting

  Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

  NCT06572228· Phase 4· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  A Study to Evaluate Solrikitug in Participants With COPD (ZION)

  NCT06496620· Phase 2· Uniquity One (UNI)· Source

• Active, not recruiting

  A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT05559359· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting

Closed trials

• Completed

  A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

  NCT05571943· Phase 3· Acrotech Biopharma Inc.· Source

• Completed

  A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

  NCT05505734· Phase 3· Bond Avillion 2 Development LP· Source